Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Concetta Iside

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The International Journal of Biochemistry & Cell Biology|October 24, 2015
Epigenetic-based therapy: From single- to multi-target approachesRosaria Benedetti, Mariarosaria Conte, Concetta Iside, et al.
Frontiers in Pharmacology|August 28, 2020
SIRT1 Activation by Natural Phytochemicals: An OverviewConcetta Iside, Marika Scafuro, Angela Nebbioso, et al.
Expert Opinion on Therapeutic Targets|June 2, 2015
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemiaAngela Nebbioso, Rosaria Benedetti, Mariarosaria Conte, et al.
Journal of Clinical Medicine|October 28, 2023
Stratification of Patients with Coronary Artery Disease by Circulating Cytokines Profile: A Pilot StudyConcetta Iside, Ornella Affinito, Bruna Punzo, et al.
American Journal of Physiology. Cell Physiology|May 7, 2025
TRIB1: a multifaceted regulator of cardiometabolic healthValeria Prete, Paola Di Pietro, Angela Carmelita Abate, et al.
International Journal of Molecular Sciences|February 13, 2025
Lymphocyte Subset Imbalance in Cardiometabolic Diseases: Are T Cells the Missing Link?Francesca Picone, Valentina Giudice, Concetta Iside, et al.
Journal of Translational Medicine|March 16, 2024
Identification of therapeutic targets in osteoarthritis by combining heterogeneous transcriptional datasets, drug-induced expression profiles, and known drug-target interactionsMaria Claudia Costa, Claudia Angelini, Monica Franzese, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2018
Oxidative nucleophilic substitution selectively produces cambinol derivatives with antiproliferative activity on bladder cancer cell linesLorenzo Botta, Silvia Filippi, Bruno Mattia Bizzarri, et al.
Cancer Cell International|December 1, 2022
Specific lncRNA signatures discriminate childhood acute leukaemias: a pilot studyLorena Buono, Concetta Iside, Antonia De Matteo, et al.
International Journal of Molecular Sciences|November 13, 2025
MicroRNA Signatures in Cardiometabolic Disorders as a Next-Generation Diagnostic Approach: Current InsightConcetta Iside, Francesca Picone, Paola Di Pietro, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The International Journal of Biochemistry & Cell Biology|October 24, 2015
Epigenetic-based therapy: From single- to multi-target approachesRosaria Benedetti, Mariarosaria Conte, Concetta Iside, et al.
Frontiers in Pharmacology|August 28, 2020
SIRT1 Activation by Natural Phytochemicals: An OverviewConcetta Iside, Marika Scafuro, Angela Nebbioso, et al.
Expert Opinion on Therapeutic Targets|June 2, 2015
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemiaAngela Nebbioso, Rosaria Benedetti, Mariarosaria Conte, et al.
Journal of Clinical Medicine|October 28, 2023
Stratification of Patients with Coronary Artery Disease by Circulating Cytokines Profile: A Pilot StudyConcetta Iside, Ornella Affinito, Bruna Punzo, et al.
American Journal of Physiology. Cell Physiology|May 7, 2025
TRIB1: a multifaceted regulator of cardiometabolic healthValeria Prete, Paola Di Pietro, Angela Carmelita Abate, et al.
International Journal of Molecular Sciences|February 13, 2025
Lymphocyte Subset Imbalance in Cardiometabolic Diseases: Are T Cells the Missing Link?Francesca Picone, Valentina Giudice, Concetta Iside, et al.
Journal of Translational Medicine|March 16, 2024
Identification of therapeutic targets in osteoarthritis by combining heterogeneous transcriptional datasets, drug-induced expression profiles, and known drug-target interactionsMaria Claudia Costa, Claudia Angelini, Monica Franzese, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2018
Oxidative nucleophilic substitution selectively produces cambinol derivatives with antiproliferative activity on bladder cancer cell linesLorenzo Botta, Silvia Filippi, Bruno Mattia Bizzarri, et al.
Cancer Cell International|December 1, 2022
Specific lncRNA signatures discriminate childhood acute leukaemias: a pilot studyLorena Buono, Concetta Iside, Antonia De Matteo, et al.
International Journal of Molecular Sciences|November 13, 2025
MicroRNA Signatures in Cardiometabolic Disorders as a Next-Generation Diagnostic Approach: Current InsightConcetta Iside, Francesca Picone, Paola Di Pietro, et al.
Pageof 2